Publication | Closed Access

Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group

National Cancer InstituteMedicinePharmacologyPathologyPhase Ii StudyMolecular OncologyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyChemotherapyCancer Research